These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20957672)

  • 1. LL-37 as a therapeutic target for late stage prostate cancer.
    Hensel JA; Chanda D; Kumar S; Sawant A; Grizzle WE; Siegal GP; Ponnazhagan S
    Prostate; 2011 May; 71(6):659-70. PubMed ID: 20957672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages.
    Cha HR; Lee JH; Hensel JA; Sawant AB; Davis BH; Lee CM; Deshane JS; Ponnazhagan S
    Prostate; 2016 May; 76(7):624-36. PubMed ID: 26856684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells.
    Wu WK; Sung JJ; To KF; Yu L; Li HT; Li ZJ; Chu KM; Yu J; Cho CH
    J Cell Physiol; 2010 Apr; 223(1):178-86. PubMed ID: 20054823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of arginase II alters prostate tumor formation in TRAMP mice.
    Mumenthaler SM; Rozengurt N; Livesay JC; Sabaghian A; Cederbaum SD; Grody WW
    Prostate; 2008 Oct; 68(14):1561-9. PubMed ID: 18663728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MS4A8B promotes cell proliferation in prostate cancer.
    Ye L; Yao XD; Wan FN; Qu YY; Liu ZY; Shen XX; Li S; Liu XJ; Yue F; Wang N; Dai B; Ye DW
    Prostate; 2014 Jun; 74(9):911-22. PubMed ID: 24789009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma.
    Hafeez BB; Zhong W; Weichert J; Dreckschmidt NE; Jamal MS; Verma AK
    Cancer Res; 2011 Mar; 71(6):2318-27. PubMed ID: 21406403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.
    Kurosaka K; Chen Q; Yarovinsky F; Oppenheim JJ; Yang D
    J Immunol; 2005 May; 174(10):6257-65. PubMed ID: 15879124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury.
    Bei Y; Pan LL; Zhou Q; Zhao C; Xie Y; Wu C; Meng X; Gu H; Xu J; Zhou L; Sluijter JPG; Das S; Agerberth B; Sun J; Xiao J
    BMC Med; 2019 Feb; 17(1):42. PubMed ID: 30782145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression.
    Long MD; Singh PK; Russell JR; Llimos G; Rosario S; Rizvi A; van den Berg PR; Kirk J; Sucheston-Campbell LE; Smiraglia DJ; Campbell MJ
    Oncogene; 2019 Jan; 38(3):421-444. PubMed ID: 30120411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model.
    Pu H; Collazo J; Jones E; Gayheart D; Sakamoto S; Vogt A; Mitchell B; Kyprianou N
    Cancer Res; 2009 Sep; 69(18):7366-74. PubMed ID: 19738062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis.
    Kienhöfer D; Hahn J; Schubert I; Reinwald C; Ipseiz N; Lang SC; Borràs ÈB; Amann K; Sjöwall C; Barron AE; Hueber AJ; Agerberth B; Schett G; Hoffmann MH
    PLoS One; 2014; 9(12):e115474. PubMed ID: 25535966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the antimicrobial peptide cathelicidin in myeloid cells is required for lung tumor growth.
    Li D; Beisswenger C; Herr C; Schmid RM; Gallo RL; Han G; Zakharkina T; Bals R
    Oncogene; 2014 May; 33(21):2709-16. PubMed ID: 23812430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer.
    Jeet V; Ow K; Doherty E; Curley B; Russell PJ; Khatri A
    Prostate; 2008 Apr; 68(5):548-62. PubMed ID: 18247402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling.
    Ji P; Zhou Y; Yang Y; Wu J; Zhou H; Quan W; Sun J; Yao Y; Shang A; Gu C; Zeng B; Firrman J; Xiao W; Bals R; Sun Z; Li D
    Theranostics; 2019; 9(8):2209-2223. PubMed ID: 31149039
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.
    Schmittgen TD; Zakrajsek BA; Hill RE; Liu Q; Reeves JJ; Axford PD; Singer MJ; Reed MW
    Prostate; 2003 Jun; 55(4):308-16. PubMed ID: 12712410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of p21/Cdkn1a confers protective effect against prostate tumorigenesis in transgenic adenocarcinoma of the mouse prostate model.
    Jain AK; Raina K; Agarwal R
    Cell Cycle; 2013 May; 12(10):1598-604. PubMed ID: 23624841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition.
    Luo W; Tan P; Rodriguez M; He L; Tan K; Zeng L; Siwko S; Liu M
    J Biol Chem; 2017 Sep; 292(37):15525-15537. PubMed ID: 28768769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens.
    Granchi S; Brocchi S; Bonaccorsi L; Baldi E; Vinci MC; Forti G; Serio M; Maggi M
    Prostate; 2001 Dec; 49(4):267-77. PubMed ID: 11746273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.